Metabolism and cancer-select topics

Abstract

Metabolism and cancer intersect in multiple ways. Cancer has unique metabolic properties, including an inordinate reliance on anaerobic glycolysis (the Warburg effect). From an evolutionary standpoint, increased cancer incidence is associated with increased metabolic rates across species. Epidemiological data prove that a group of overlapping metabolic alterations, including obesity, type 2 diabetes Mellitus, nonalcoholic fatty liver disease, and metabolic syndrome, constitute predisposing risk factors for cancer development in multiple anatomical sites. The molecular pathways underpinning this association involve hyperinsulinemia, hyperglycemia, sex hormones, adipokines, chronic inflammation, oxidative stress, and altered immune response.

Keywords

Cancer / metabolism / type 2 diabetes Mellitus (T2DM) / obesity

References

[1] Kelly T,Chen CS,He J.Global burden of obesity in 2005 and projections to 2030.Int J Obes (Lond)2008;32:1431-7

[2] Porporato PE.Understanding cachexia as a cancer metabolism syndrome.Oncogenesis2016;5:e200 PMCID:PMC5154342

[3] Potter M,Morten KJ.The Warburg effect: 80 years on.Biochem Soc Trans2016;44:1499-505 PMCID:PMC5095922

[4] Zambrano A,Uribe E.Glut 1 in cancer cells and the inhibitory action of resveratrol as a potential therapeutic strategy.Int J Mol Sci2019;20:3374 PMCID:PMC6651361

[5] Hanahan D.Hallmarks of cancer: the next generation.Cell2011;144:646-74

[6] Huang J,Tu L,Hang L.Isocitrate dehydrogenase mutations in glioma: from basic discovery to therapeutics development.Front Oncol2019;9:506 PMCID:PMC6584818

[7] Liberti MV.The Warburg Effect: how does it benefit cancer cells?.Trends Biochem Sci2016;41:211-8 PMCID:PMC4783224

[8] Angelin A,Dahiya S.Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments.Cell Metab2017;25:1282-1293.e7 PMCID:PMC5462872

[9] Grzes KM,Pearce EJ.Treg cells survive and thrive in inhospitable environments.Cell Metab2017;25:1213-5

[10] Shen F,Pauly R,Chandrasekaran S.Genome-scale network model of metabolism and histone acetylation reveals metabolic dependencies of histone deacetylase inhibitors.Genome Biol2019;20:49 PMCID:PMC6397465

[11] Lu C.Metabolic regulation of epigenetics.Cell Metab2012;16:9-17 PMCID:PMC3392647

[12] Evertts AG,Dimaggio PA,Coller HA.Quantitative dynamics of the link between cellular metabolism and histone acetylation.J Biol Chem2013;288:12142-51 PMCID:PMC3636898

[13] Cluntun AA,Dai L,Zhao Y.The rate of glycolysis quantitatively mediates specific histone acetylation sites.Cancer Metab2015;3:10 PMCID:PMC4579576

[14] Monferrer E,López-Carrasco A.Metabolic classification and intervention opportunities for tumor energy dysfunction.Metabolites2021;11:264 PMCID:PMC8146396

[15] Tollis M,Maley CC.Peto’s paradox: how has evolution solved the problem of cancer prevention?.BMC Biol2017;15:60 PMCID:PMC5513346

[16] Dang CV.A metabolic perspective of Peto’s paradox and cancer.Philos Trans R Soc Lond B Biol Sci2015;370:20140223 PMCID:PMC4581028

[17] Dang CV.Links between metabolism and cancer.Genes Dev2012;26:877-90 PMCID:PMC3347786

[18] Niklas KJ.Kleiber’s Law: How the fire of life ignited debate, fueled theory, and neglected plants as model organisms.Plant Signal Behav2015;10:e1036216 PMCID:PMC4622013

[19] Kliemann N,Viallon V.Predicted basal metabolic rate and cancer risk in the european prospective investigation into cancer and nutrition.Int J Cancer2020;147:648-61

[20] Redman LM.Caloric restriction in humans: impact on physiological, psychological, and behavioral outcomes.Antioxid Redox Signal2011;14:275-87 PMCID:PMC3014770

[21] Meynet O.Caloric restriction and cancer: molecular mechanisms and clinical implications.Trends Mol Med2014;20:419-27

[22] Hursting SD,Lashinger LM,Perkins SN.Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research.Carcinogenesis2010;31:83-9

[23] Bray GA.Obesity: basic considerations and clinical approaches.Disease-a-Month1989;35:454-537

[24] Leibel RL,Hirsch J.Changes in energy expenditure resulting from altered body weight.N Engl J Med1995;332:621-8

[25] Miller WM,Zalesin KC.Lower than predicted resting metabolic rate is associated with severely impaired cardiorespiratory fitness in obese individuals.Obesity (Silver Spring)2012;20:505-11

[26] Carneiro IP,Siervo M.Is obesity associated with altered energy expenditure?.Adv Nutr2016;7:476-87 PMCID:PMC4863259

[27] Bessard T,Jéquier E.Energy expenditure and postprandial thermogenesis in obese women before and after weight loss..Am J Clin Nutr1983;38:680-93

[28] Lemmer JT,Ryan AS.Effect of strength training on resting metabolic rate and physical activity: age and gender comparisons.Med Sci Sports Exerc2001;33:532-41

[29] Pannemans DL.Energy expenditure, physical activity and basal metabolic rate of elderly subjects.Br J Nutr1995;73:571-81

[30] Speakman JR.Physical activity and resting metabolic rate.Proc Nutr Soc2003;62:621-34

[31] Pontzer H,Dugas LR.Constrained total energy expenditure and metabolic adaptation to physical activity in adult humans.Curr Biolo2016;26:410-7 PMCID:PMC4803033

[32] Westerterp KR,Janssen EM,Ten Hoor F.Long-term effect of physical activity on energy balance and body composition.Br J Nutr1992;68:21-30

[33] Calle EE,Walker-Thurmond K.Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.N Engl J Med2003;348:1625-38

[34] Pergola G, Silvestris F. Obesity as a major risk factor for cancer.J Obes2013;2013:291546

[35] Lega IC.Review: diabetes, obesity, and cancer-pathophysiology and clinical implications.Endocr Rev2020;41:33-52

[36] Renehan AG,Tyson M.Incident cancer burden attributable to excess body mass index in 30 European countries.Int J Cancer2010;126:692-702

[37] Rawla P.Epidemiology of prostate cancer.World J Oncol2019;10:63-89 PMCID:PMC6497009

[38] Kinsella N,Bruinsma S.Active surveillance for prostate cancer: a systematic review of contemporary worldwide practices.Transl Androl Urol2018;7:83-97 PMCID:PMC5861285

[39] Golabek T,Chłosta P,Dobruch J.Obesity and prostate cancer incidence and mortality: a systematic review of prospective cohort studies.Urol Int2014;92:7-14

[40] Dickerman BA,Valdimarsdottir UA.Midlife metabolic factors and prostate cancer risk in later life.International Journal of Cancer2018;142:1166-73

[41] Lonardo A.The “obese liver” and gastrointestinal cancer risk.Transl Gastroenterol Hepatol2020;5:44 PMCID:PMC7063505

[42] Mantovani A,Beatrice G.Nonalcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies.Gut2022;71:778-88

[43] McGlynn KA,El-Serag HB.Epidemiology of hepatocellular carcinoma.Hepatology2021;73 Suppl 1:4-13 PMCID:PMC7577946

[44] Smith L,Spitz MR.Body mass index and risk of lung cancer among never, former, and current smokers.J Natl Cancer Inst2012;104:778-89 PMCID:PMC3352831

[45] ten Haaf K,Tammemägi MC.Risk prediction models for selection of lung cancer screening candidates: a retrospective validation study.PLoS Med2017;14:e1002277 PMCID:PMC5380315

[46] Dahlberg SE,Bonomi PB.Body mass index and its association with clinical outcomes for advanced non-small-cell lung cancer patients enrolled on Eastern Cooperative Oncology Group clinical trials.J Thorac Oncol2013;8:1121-7 PMCID:PMC3763835

[47] Leung CC,Yew WW,Law WS.Lower lung cancer mortality in obesity.Int J Epidemiol2011;40:174-82

[48] Barbi J,Pabla S.Visceral obesity promotes lung cancer progression-toward resolution of the obesity paradox in lung cancer.J Thorac Oncol2021;16:1333-48

[49] Yu D,Johansson M.Overall and central obesity and risk of lung cancer: a pooled analysis.J Natl Cancer Inst2018;110:831-42 PMCID:PMC6093439

[50] Nattenmüller J,Muley T.Prognostic impact of CT-quantified muscle and fat distribution before and after first-line-chemotherapy in lung cancer patients.PLoS One2017;12:e0169136 PMCID:PMC5249228

[51] Iwase T,Fujimoto H.Quality and quantity of visceral fat tissue are associated with insulin resistance and survival outcomes after chemotherapy in patients with breast cancer.Breast Cancer Res Treat2020;179:435-43

[52] Fujiwara N,Kudo Y.Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.J Hepatol2015;63:131-40

[53] Donkers H,Mcgrane J.The role of sarcopenic obesity in high-grade endometrial cancer.Int J Gynaecol Obstet2021;154:248-55

[54] Lee JY,Lee DC.Visceral fat accumulation is associated with colorectal cancer in postmenopausal women.PLoS One2014;9:e110587 PMCID:PMC4234311

[55] Park JW,Lim JS.Impact of visceral fat on survival and metastasis of stage III colorectal cancer.Gut Liver2022;16:53-61 PMCID:PMC8761926

[56] Allen AM,Mara KC,Therneau TM.The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - a longitudinal cohort study.J Hepatol2019;71:1229-36 PMCID:PMC6921701

[57] Marchesini G,Cortez-Pinto H.Adipose tissue-associated cancer risk: Is it the fat around the liver, or the fat inside the liver?.J Hepatol2019;71:1073-5

[58] Fernandez CJ,Subrahmanyan NA.Epidemiological link between obesity, type 2 diabetes mellitus and cancer.World J Methodol2021;11:23-45 PMCID:PMC8127420

[59] Saydah SH,Rifai N,Brancati F.Association of markers of insulin and glucose control with subsequent colorectal cancer risk.Cancer Epidemiol Biomarkers Prev2003;12:412-8

[60] Ozasa K,Suzuki K.JACC Study GroupGlucose intolerance and colorectal cancer risk in a nested case-control study among Japanese people.J Epidemiol2005;15 Suppl 2:S180-4 PMCID:PMC8639045

[61] Yuhara H,Cohen SE,Tei Y.Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer?.Am J Gastroenterol2011;106:1911-21; quiz 1922 PMCID:PMC3741453

[62] Zhu B,Wu B,Zhang L.The relationship between diabetes and colorectal cancer prognosis: a meta-analysis based on the cohort studies.PLoS One2017;12:e0176068 PMCID:PMC5397066

[63] Krämer HU,Stegmaier C,Raum E.Type 2 diabetes mellitus and gender-specific risk for colorectal neoplasia.Eur J Epidemiol2012;27:341-7

[64] Mauvais-jarvis F,Barnes PJ.Sex and gender: modifiers of health, disease, and medicine.The Lancet2020;396:565-82 PMCID:PMC7440877

[65] Esposito K,Capuano A,Maiorino MI.Metabolic syndrome and endometrial cancer: a meta-analysis.Endocrine2014;45:28-36

[66] Trabulo D,Martins C.Metabolic syndrome and colorectal neoplasms: An ominous association.World J Gastroenterol2015;21:5320-7 PMCID:PMC4419073

[67] Kaleru T,Maheshwary A,Khan S.Diabetes mellitus in the middle-aged and elderly population (> 45 years) and its association with pancreatic cancer: an updated review.Cureus2020;12:e8884 PMCID:PMC7388804

[68] Zhang Y,Xiao H.Metformin actions on the liver: protection mechanisms emerging in hepatocytes and immune cells against NASH-related HCC.Int J Mol Sci2021;22:5016 PMCID:PMC8126028

[69] Zampaglione L,Pedica F.HCC in metabolic syndrome: current concepts and future directions.Hepatoma Res2021;7:55

[70] Tseng CH.The Relationship between diabetes mellitus and gastric cancer and the potential benefits of metformin: an extensive review of the literature.Biomolecules2021;11:1022 PMCID:PMC8301937

[71] Sjöström L,Sjöström CD.Swedish Obese Subjects StudyEffects of bariatric surgery on mortality in Swedish obese subjects.N Engl J Med2007;357:741-52

[72] Renehan AG,Egger M,Zwahlen M.Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies.The Lancet2008;371:569-78

[73] Wiggins T,Welbourn R,Markar SR.Association of bariatric surgery with all-cause mortality and incidence of obesity-related disease at a population level: a systematic review and meta-analysis.PLoS Med2020;17:e1003206 PMCID:PMC7386646

[74] McTiernan A,Katzmarzyk PT.2018 PHYSICAL ACTIVITY GUIDELINES ADVISORY COMMITTEE*Physical activity in cancer prevention and survival: a systematic review.Med Sci Sports Exerc2019;51:1252-61 PMCID:PMC6527123

[75] Holmes MD,Feskanich D,Colditz GA.Physical activity and survival after breast cancer diagnosis.JAMA2005;293:2479-86

[76] Van Blarigan EL,Niedzwiecki D.Association of survival with adherence to the american cancer society nutrition and physical activity guidelines for cancer survivors after colon cancer diagnosis: The CALGB 89803/alliance trial.JAMA Oncol2018;4:783-90 PMCID:PMC6145685

[77] Lugo D,Mihos CG.The effects of physical activity on cancer prevention, treatment and prognosis: a review of the literature.Complement Ther Med2019;44:9-13

[78] Meyerhardt JA,Holmes MD.Physical activity and survival after colorectal cancer diagnosis.J Clin Oncol2006;24:3527-34

[79] Haydon AM,English DR.Effect of physical activity and body size on survival after diagnosis with colorectal cancer.Gut2006;55:62-7 PMCID:PMC1856365

[80] Irwin ML,McTiernan A.Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study.J Clin Oncol2008;26:3958-64 PMCID:PMC2654316

[81] Jones LW,Weltzien E.Exercise and risk of cardiovascular events in women with nonmetastatic breast cancer.J Clin Oncol2016;34:2743-9 PMCID:PMC5019746

[82] Ashcraft KA,Betof AS,Jones LW.Efficacy and mechanisms of aerobic exercise on cancer initiation, progression, and metastasis: a critical systematic review of in vivo preclinical data.Cancer Res2016;76:4032-50 PMCID:PMC5378389

[83] Pedersen L,Hojman P.Effects of exercise on tumor physiology and metabolism.Cancer J2015;21:111-6

[84] Kurgan N,Kouvelioti R,Klentrou P.Inhibition of human lung cancer cell proliferation and survival by post-exercise serum is associated with the inhibition of Akt, mTOR, p70 S6K, and Erk1/2.Cancers (Basel)2017;9:46 PMCID:PMC5447956

[85] Dethlefsen C,Lillelund C.Exercise-induced catecholamines activate the hippo tumor suppressor pathway to reduce risks of breast cancer development.Cancer Res2017;77:4894-904

[86] Rundqvist H,Strömberg A.Effect of acute exercise on prostate cancer cell growth.PLoS One2013;8:e67579 PMCID:PMC3702495

[87] Betof AS,Weitzel D.Modulation of murine breast tumor vascularity, hypoxia and chemotherapeutic response by exercise.J Natl Cancer Inst2015;107:djv040 PMCID:PMC4822524

[88] Schadler KL,Galie PA.Tumor vessel normalization after aerobic exercise enhances chemotherapeutic efficacy.Oncotarget2016;7:65429-40 PMCID:PMC5323166

[89] Arfianti A,Barn V.Exercise retards hepatocarcinogenesis in obese mice independently of weight control.J Hepatol2020;73:140-8

[90] Giovannucci E,Archer MC.Diabetes and cancer: a consensus report.Diabetes Care2010;33:1674-85 PMCID:PMC2890380

[91] Brandhorst S.Fasting and caloric restriction in cancer prevention and treatment.Recent Results Cancer Res2016;207:241-66 PMCID:PMC7476366

[92] Sohal RS.Oxidative stress, caloric restriction, and aging.Science1996;273:59-63 PMCID:PMC2987625

[93] Longo VD.Chronological aging in Saccharomyces cerevisiae.Subcell Biochem2012;57:101-21 PMCID:PMC4048025

[94] Ibrahim EM,Al-Mansour MM.Energy and caloric restriction, and fasting and cancer: a narrative review.Support Care Cancer2021;29:2299-304 PMCID:PMC7981322

[95] Chen Y,Su G.Effect of intermittent versus chronic calorie restriction no tumor incidence: a systematic review and meta-analysis of animal studies.Sci Rep2016;6:337379 PMCID:PMC5031958

[96] Nencioni A,Cortellino S.Fasting and cancer: molecular mechanisms and clinical applications.Nat Rev Cancer2018;18:707-19 PMCID:PMC6938162

[97] Bowker SL,Veugelers P.Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: Response to Farooki and Schneider.Diabetes Care2006;29:1990-1

[98] Soranna D,Zambon A.Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis.Oncologist2012;17:813-822 PMCID:PMC3380880

[99] Evans JM,Emslie-Smith AM,Morris AD.Metformin and reduced risk of cancer in diabetic patients.BMJ2005;330:1304-5 PMCID:PMC558205

[100] Landman GW,van Hateren KJ,Gans RO.Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16.Diabetes Care2010;33:322-6 PMCID:PMC2809274

[101] Feng Z,Liu N,Chen X.Metformin use and prostate cancer risk: A meta-analysis of cohort studies.Medicine (Baltimore)2019;98:e14955 PMCID:PMC6709307

[102] Zhang K,Dai H.Metformin and risk of cancer among patients with type 2 diabetes mellitus: a systematic review and meta-analysis.Prim Care Diabetes2021;15:52-8

[103] Wang Z,Xie L.Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Res Clin Pract 2014;106:19-26.

[104] Winston Ng CA,Shuen Toh EM.Metfornin and colorectal cancer: a systemtaic review, meta-analysis and meta-regression.Int J Colorectal Dis2020;35:1501-12

[105] Hu J,Cui Y.Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: A systematic review and meta-analysis.Medicine (Baltimore)2018;97:e11596 PMCID:PMC6078654

[106] Chu D,Wang K.Effect of metformin use on the risk and prognosis of endometrial cancer.BMC Cancer2018;18:438 PMCID:PMC5907461

[107] Gallagher EJ.Obesity and diabetes: the increased risk of cancer and cancer-related mortality.Physiol Rev2015;95:727-48 PMCID:PMC4491542

[108] Pisani P.Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies.Arch Physiol Biochem2008;114:63-70

[109] Tsujimoto T,Sugiyama T.Association between hyperinsulinemia and increased risk of cancer death in nonobese and obese people: a population-based observational study.Int J Cancer2017;141:102-11 PMCID:PMC5435954

[110] Giovannucci E.Insulin, insulin-like growth factors and colon cancer: a review of the evidence.J Nutr2001;131:3109S-20S

[111] Guevara-Aguirre J,Torres C.Insights from the clinical phenotype of subjects with Laron syndrome in Ecuador.Rev Endocr Metab Disord2021;22:59-70

[112] 10.1007/s11154-020-096024112. Steuerman R, Shevah O, Laron Z. Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies.Eur J Endocrinol2011;164:485-9

[113] Hou Y,Xie J,Feng Q.High glucose levels promote the proliferation of breast cancer cells through GTPases.Breast Cancer (Dove Med Press)2017;9:429-36 PMCID:PMC5479300

[114] Han L,Li J.High glucose promotes pancreatic cancer cell proliferation via the induction of EGF expression and transactivation of EGFR.PLoS One2011;6:e27074 PMCID:PMC3210779

[115] Li W,Sang H.Effects of hyperglycemia on the progression of tumor diseases.J Exp Clin Cancer Res2019;38:327 PMCID:PMC6651927

[116] Saengboonmee C,Pairojkul C.High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation.Sci Rep2016;6:18995 PMCID:PMC4705543

[117] Kang X,Wu X.High glucose promotes tumor invasion and increases metastasis-associated protein expression in human lung epithelial cells by upregulating heme oxygenase-1 via reactive oxygen species or the TGF-β1/PI3K/Akt signaling pathway.Cell Physiol Biochem2015;35:1008-22

[118] Alisson-Silva F,Donadio JL.Increase of O-glycosylated oncofetal fibronectin in high glucose-induced epithelial-mesenchymal transition of cultured human epithelial cells.PLoS One2013;8:e60471 PMCID:PMC3625189

[119] Rahn S,Viol F.Diabetes as a risk factor for pancreatic cancer: hyperglycemia promotes epithelial-mesenchymal-transition and stem cell properties in pancreatic ductal epithelial cells.Cancer Lett2018;415:129-50

[120] Sun XF,Liu MG.High-concentration glucose enhances invasion in invasive ductal breast carcinoma by promoting Glut1/MMP2/MMP9 axis expression.Oncol Lett2017;13:2989-95 PMCID:PMC5431328

[121] Flores-López LA,Viedma-Rodríguez R,Baiza-Gutman LA.High glucose and insulin enhance uPA expression, ROS formation and invasiveness in breast cancer-derived cells.Cell Oncol (Dordr)2016;39:365-78

[122] Li W,Ma J.Hydrogen peroxide mediates hyperglycemia-induced invasive activity via ERK and p38 MAPK in human pancreatic cancer.Oncotarget2015;6:31119-33 PMCID:PMC4741592

[123] Cao L,Xiao X,Li W.Resveratrol inhibits hyperglycemia-driven ROS-induced invasion and migration of pancreatic cancer cells via suppression of the ERK and p38 MAPK signaling pathways.Int J Oncol2016;49:735-43

[124] Baldari S,Granato M.Hyperglycemia triggers HIPK2 protein degradation.Oncotarget2017;8:1190-203 PMCID:PMC5352047

[125] Garufi A,Baldari S,Cirone M.p53-dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions.J Exp Clin Cancer Res2017;36:126 PMCID:PMC5594515

[126] Esposito K,Marfella R.Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress.Circulation2002;106:2067-72

[127] Ramteke P,Shepal V.Hyperglycemia associated metabolic and molecular alterations in cancer risk, progression, treatment, and mortality.Cancers (Basel)2019;11:1402 PMCID:PMC6770430

[128] Ma YS,Tsai HL,Juo SH.High glucose modulates antiproliferative effect and cytotoxicity of 5-fluorouracil in human colon cancer cells.DNA Cell Biol2014;33:64-72 PMCID:PMC3929122

[129] Zhao W,Zhao M,Fan L.High glucose promotes gastric cancer chemoresistance in vivo and in vitro.Mol Med Rep2015;12:843-50 PMCID:PMC4438965

[130] Biernacka KM,Zeng L.Hyperglycaemia-induced chemoresistance of prostate cancer cells due to IGFBP2.Endocr Relat Cancer2013;20:741-51

[131] Qahtani A, Holly J, Perks C. Hypoxia negates hyperglycaemia-induced chemo-resistance in breast cancer cells: the role of insulin-like growth factor binding protein 2.Oncotarget2017;8:74635-48 PMCID:PMC5650368

[132] Morice P,Creutzberg C,Darai E.Endometrial cancer.Lancet2016;387:1094-108

[133] Simó R,Barbosa-Desongles A,Selva DM.Novel insights in SHBG regulation and clinical implications.Trends Endocrinol Metab2015;26:376-83

[134] Simó R,Hernandez C.IL1β down-regulation of sex hormone-binding globulin production by decreasing HNF-4α via MEK-1/2 and JNK MAPK pathways.Mol Endocrinol2012;26:1917-27 PMCID:PMC5416961

[135] Bhardwaj P,Benito-Martin A.Estrogens and breast cancer: Mechanisms involved in obesity-related development, growth and progression.J Steroid Biochem Mol Biol2019;189:161-70 PMCID:PMC6502693

[136] Yu Z,Ma H,Zeng Y.Association of serum adiponectin with breast cancer: a meta-analysis of 27 case-control studies.Medicine (Baltimore)2019;98:e14359 PMCID:PMC6380750

[137] Mantzoros C,Dessypris N.Adiponectin and breast cancer risk.J Clin Endocrinol Metab2004;89:1102-7

[138] Tworoger SS,Kelesidis T.Plasma adiponectin concentrations and risk of incident breast cancer.J Clin Endocrinol Metab2007;92:1510-6

[139] Dal Maso L,Karalis A.Circulating adiponectin and endometrial cancer risk.J Clin Endocrinol Metab2004;89:1160-3

[140] Cust AE,Friedenreich C.Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women.J Clin Endocrinol Metab2007;92:255-63

[141] Wei EK,Fuchs CS,Mantzoros CS.Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study.J Natl Cancer Inst2005;97:1688-94

[142] Candia P, Prattichizzo F, Garavelli S, Alviggi C, La Cava A, Matarese G. The pleiotropic roles of leptin in metabolism, immunity, and cancer.J Exp Med2021;218:e20191593

[143] Crean-Tate KK.Leptin regulation of cancer stem cells in breast and gynecologic cancer.Endocrinology2018;159:3069-80 PMCID:PMC6669812

[144] Slattery ML,Poole EM.Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival.Int J Cancer2011;128:2726-34 PMCID:PMC3229275

[145] Ye J.Regulation of energy metabolism by inflammation: a feedback response in obesity and calorie restriction.Aging (Albany NY)2010;2:361-8 PMCID:PMC2919256

[146] Moulin CM,Halpern A.Effect of surgery-induced weight loss on immune function.Expert Rev Gastroenterol Hepatol200;2:617-9

[147] Ringel AE,Baker GJ.Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity.Cell2020;183:1848-1866.e26 PMCID:PMC8064125

[148] Allot EH,Freeland SJ.Obesity and prostate cancer: weighing the evidence.Eur Urol2013;63:800-9 PMCID:PMC3597763

[149] Dickerman BA,Valdimarsdottir UA.Body fat distribution on computed tomography imaging and prostate cancer risk and mortality in the AGES-Reykjavik study.Cancer2019;125:2877-85 PMCID:PMC6663585

[150] Møller H,Van Hemelrijck M.Prostate cancer incidence, clinical stage and survival in relation to obesity: a prospective cohort study in Denmark.Int J Cancer2015;136:1940-7

[151] Vidal AC,Moreira DM,Andriole GL Jr.Obesity increases the risk for high-grade prostate cancer: results from the REDUCE study.Cancer Epidemiol Biomarkers Prev2014;23:2936-42 PMCID:PMC4257871

[152] Haque R,Wallner LP.Association of body mass index and prostate cancer mortality.Obes Res Clin Pract2014;8:e374-81 PMCID:PMC4122983

[153] Yamoah K,Jeffers A.The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancer.BMC Cancer2016;16:557 PMCID:PMC4966583